Acute Porphyria Drug Database

Monograph

A10BD10 - Metformin and Saxagliptin
Propably not porphyrinogenic
PNP

Rationale
Combination of two substances classified as NP (metformin) and PNP (saxagliptin). For more extensive monographs, please search the individual substances metformin (ATC A10BA02) and saxagliptin (ATC A10BH03) in this database.
Chemical description
Metformin is a biguanide antidiabetic. Saxagliptin is a dipeptidyl peptidase-4 inhibitor.

Similar drugs
Explore alternative drugs in similar therapeutic classes A10B / A10BD or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Komboglyze · Komboglyze 2.5 mg/1000 mg, filmomhulde tabletten · Komboglyze 2.5 mg/850 mg, filmomhulde tabletten
Belgium
Komboglyze · Komboglyze 2.5 mg - 1 000 mg compr. pellic. · Komboglyze 2.5 mg - 850 mg compr. pellic.
United Kingdom
Komboglyze · Komboglyze 2.5mg/1000mg tablets · Komboglyze 2.5mg/850mg tablets
Denmark
Komboglyze
Poland
Komboglyze
Luxembourg
Komboglyze
Iceland
Komboglyze
Finland
Komboglyze
Latvia
Komboglyze
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙